Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Imaging of tumor infiltrating T cells with an anti-CD8 minibody 89Zr-IAB22M2C in advanced solid tumors: A phase I first-in-human study
    Meeting Abstract

    Gordon, M. S.; Tsai, F.; Postow, M.; Hellmann, M.; Harding, J. J.; Korn, R. L.; Farwell, M. D.; Mitchell, T. C.; Schuchter, L. M.; Ziolkowska, M.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • In silico assessment of variation in TMB quantification across diagnostic platforms: Phase 1 of the Friends of Cancer Research Harmonization Project
    Meeting Abstract

    Fabrizio, D.; Chen, S. J.; Xie, M.; Chen, W.; Quin, K. J.; Zhao, C.; Zehir, A.; Funari, V.; Dickey, J. S.; Gupta, V.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Peripheral T cell dynamics in resectable NSCLC patients treated with neoadjuvant PD-1 blockade
    Meeting Abstract

    Zhang, J.; Ji, Z.; El Asmar, M.; Caushi, J.; Anagnostou, V.; Chan, H. Y.; Suri, P.; Guo, H.; Marrone, K.; Naidoo, J.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Refractory renal cell cancer (RCC) exhibits high adenosine A2A receptor (A2AR) expression and prolonged survival following treatment with the A2AR antagonist, CPI-444
    Meeting Abstract

    Fong, L.; Fong, L.; Powderly, J.; Luke, J.; Hotson, D.; Sznol, M.; George, S.; Choueiri, T.; Rini, B.; Hellmann, M.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • The personal vaccine, NEO-PV-01 with anti-PD1, induces neoantigenspecific de novo tumor-related immunity in patients with advanced cancer
    Meeting Abstract

    Hu-Lieskovan, S.; Govindan, R.; Naing, A.; Friedlander, T.; Margolin, K.; Lin, J.; Bhardwaj, N.; Hellmann, M.; Srinivasan, L.; Greshock, J.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Comparison of biomarker assay modalities in anti-PD-(L)1 monotherapy: A meta-analysis
    Meeting Abstract

    Lu, S.; Lu, S.; Danilova, L.; Rimm, D.; Hoyt, C.; Hellmann, M.; Taube, J.
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Tepotinib in patients with advanced non-small lung cancer (NSCLC) and MET exon 14-skipping mutations: Phase II data
    Meeting Abstract

    Sakai, H.; Felip, E.; Cortot, A. B.; Veillon, R.; Griesinger, F.; Patel, J.; Horn, L.; Mazieres, J.; De Castro Carpeno, J.; Morise, M.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Tepotinib in non-small cell lung cancer (NSCLC) with MET-exon 14 skipping mutations (METex14+) and MET amplification (METamp): A phase II trial in progress
    Meeting Abstract

    Paik, P.; Sakai, H.; Bruns, R.; Scheele, J.; Straub, J.; Felip, E.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach
    Meeting Abstract

    Tan, D. S. W.; Lassen, U. N.; Albert, C. M.; Kummar, S.; van Tilburg, C.; Dubois, S. G.; Geoerger, B.; Mascarenhas, L.; Federman, N.; Basu-Mallick, A.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • First-line nivolumab + ipilimumab in Asian patients with advanced NSCLC and high TMB (≥ 10 mut/Mb): Results from CheckMate 227
    Meeting Abstract

    Park, K.; Lee, J.; Sakai, H.; Lee, K.; Ohe, Y.; Kim, S.; Fukuhara, T.; Kang, J.; Yu, C.; Daga, H.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save